Evidence map›Paper›PMID 28622715›Full record

ArticleNanoscale research letters2017

Nanotechniques Inactivate Cancer Stem Cells.

Anatoliy N Goltsev, Natalya N Babenko, Yulia A Gaevskaya, Nikolay A Bondarovich, Tatiana G Dubrava, Maksim V Ostankov, Olga V Chelombitko, Yuriy V Malyukin, Vladimir K Klochkov, Nataliya S Kavok

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale research letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Dual-targeted therapeutic strategy combining CSC-DC-based vaccine and cisplatin overcomes chemo-resistance in experimental mice model.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Anatoliy N GoltsevInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine. cryopato@gmail.com.
Natalya N BabenkoInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine.
Yulia A GaevskayaInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine.
Nikolay A BondarovichInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine.
Tatiana G DubravaInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine.
Maksim V OstankovInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine.
Olga V ChelombitkoInstitute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Pereyaslavska Str. 23, Kharkiv, 61016, Ukraine.
Yuriy V MalyukinInstitutes for Scintillation Materials of the National Academy of Sciences of Ukraine, 60 Nauki ave, Kharkiv, 61001, Ukraine.
Vladimir K KlochkovInstitutes for Scintillation Materials of the National Academy of Sciences of Ukraine, 60 Nauki ave, Kharkiv, 61001, Ukraine.
Nataliya S KavokInstitutes for Scintillation Materials of the National Academy of Sciences of Ukraine, 60 Nauki ave, Kharkiv, 61001, Ukraine.
Institute for Problems of Cryobiology and Cryomedicine · UANational Academy of Sciences of Ukraine · UAInstitute for Scintillation Materials · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the tasks of current oncology is identification of cancer stem cells and search of therapeutic means capable of their specific inhibition. The paper presents the data on phenotype characteristics of Ehrlich carcinoma cells as convenient and easy-to-follow model of tumor growth. The evidence of cancer stem cells as a part of Ehrlich carcinoma and significance of CD44

Indexed as

Cancer stem ellsEhrlich carcinoma cellsNanocomplexes

Identifiers

PMID28622715
PMCPMC5472644
OpenAlexW2624847224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.